For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...
Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the ...
LabGenomics announced on the 24th that it has completed the development of cancer diagnostic NGS (Next-Generation Sequencing) services and will introduce them to its 100% US subsidiary, CliaLab QDx ...
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "India Oncology NGS Market Size, Share & Trends Analysis Report by End-use (Clinical Research, Hospitals & Clinics), Technology, Application, Product & ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, are forming a strategic ...
Hosted on MSN
England trials new AI tool to speed prostate cancer diagnosis, offering same-day results
England is testing a new artificial intelligence (AI) tool to speed prostate cancer diagnoses, which may save men from weeks of uncertainty about their health. The tool, which will be piloted through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback